Drug Shortage Report for RYALTRIS
Report ID | 201860 |
Drug Identification Number | 02531186 |
Brand name | RYALTRIS |
Common or Proper name | Olopatadine Hydrochloride and Mometasone Furoate Monohydrate Spray |
Company Name | GLENMARK SPECIALTY SA |
Market Status | MARKETED |
Active Ingredient(s) | MOMETASONE FUROATE |
Strength(s) | 25MCG 665MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 240 MD 1 carton |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-08-15 |
Actual start date | 2023-08-15 |
Estimated end date | 2023-11-27 |
Actual end date | 2023-11-24 |
Shortage status | Resolved |
Updated date | 2023-11-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | PLACE DU PORT 2 NEUCHÂTEL, -- SWITZERLAND 2000 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2023-11-25 | English | Compare |
v9 | 2023-11-24 | French | Compare |
v8 | 2023-11-24 | English | Compare |
v7 | 2023-11-08 | French | Compare |
v6 | 2023-11-08 | English | Compare |
v5 | 2023-10-05 | French | Compare |
v4 | 2023-10-05 | English | Compare |
v3 | 2023-08-16 | English | Compare |
v2 | 2023-08-15 | French | Compare |
v1 | 2023-08-15 | English | Compare |
Showing 1 to 10 of 10